Solasto (TSE:6197) EBIT: 円6,614 Mil (TTM As of Mar. 2026)


TSE:6197 Solasto Corp TSE:6197
59 GF Score
Price 円1,109.00
GF Value 円563.54
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Solasto EBIT?

Solasto TSE:6197 59 EBIT is 円6,614 Mil as of Mar. 2026. GuruFocus rates TSE:6197 with a GF Score™ of 59/100 and a GF Value™ of 円563.54 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Solasto's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円637 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円6,614 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Solasto's annualized ROC % for the quarter that ended in Mar. 2026 was 4.63%. Solasto's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.20%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Solasto's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.22%.

Solasto  (TSE:6197) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Solasto's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=7344 * ( 1 - 70.31% )/( (48582 + 45573)/ 2 )
=2180.4336/47077.5
=4.63 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=68750 - 12544 - ( 12400 - max(0, 23942 - 31566+12400))
=48582

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=66209 - 12971 - ( 12212 - max(0, 22605 - 30270+12212))
=45573

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Solasto's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2548/( ( (16555 + max(506, 0)) + (18597 + max(235, 0)) )/ 2 )
=2548/( ( 17061 + 18832 )/ 2 )
=2548/17946.5
=14.20 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(15992 + 179 + 2995) - (12544 + 0 + 6116)
=506

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(15541 + 116 + 2401) - (12971 + 0 + 4852)
=235

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Solasto's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=6614/106324.642
=6.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasto EBIT Related Terms

Solasto EBIT Historical Data

* Premium members only.

The historical data trend for Solasto's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasto EBIT Chart

Solasto Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,878.00 5,690.00 4,429.00 6,741.00 6,614.00

Solasto Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,170.00 2,007.00 1,952.00 2,018.00 637.00

TSE:6197 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Solasto's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solasto EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Solasto's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Solasto's EV-to-EBIT falls into.


TSE:6197
59GF Score
Solasto Corp TSE:6197
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasto EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,614 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円6,614 Mil mean?
Solasto (TSE:6197) has a EBIT of 円6,614 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Solasto.
Is Solasto's EBIT too high?
Solasto's current EBIT is 円6,614 Mil. Overall, Solasto has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasto's EBIT compare to HCA and THC?
Solasto's EBIT of 円6,614 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Solasto. Solasto's current EBIT is 円6,614 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasto stock overvalued right now?
Based on GuruFocus' analysis, Solasto (TSE:6197) is currently considered Significantly Overvalued. The stock's GF Value™ is 円563.54, compared to a current price of 円1,109.00 — trading 96.8% above its estimated fair value. The current EBIT is 円6,614 Mil. Solasto's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Solasto (TSE:6197), the current EBIT is 円6,614 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasto (TSE:6197) Overvalued in 2026?

Based on GuruFocus' analysis, Solasto stock appears to be overvalued. The current stock price of 円1,109.00 is trading 96.8% above its estimated GF Value™ of 円563.54. GuruFocus considers Solasto to be Significantly Overvalued.

Key valuation signals for TSE:6197:

  • EBIT: 円6,614 Mil
  • GF Value™: 円563.54 vs. price of 円1,109.00 (96.8% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the TSE:6197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solasto Business Description

Address 1-7-18 Konan, Minato-ku, Tokyo, JPN, 108-8210
Solasto Corp is engaged in providing medical outsourcing business, long-term care and child care business and others.
59GF Score

Get the complete analysis for TSE:6197

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,109.00
Price
円563.54
GF Value